Dermatomyositis
📧 Sign up to get email alerts when something new happens for Dermatomyositis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) [Phase 2]
Phase 2 clinical trial evaluating fatty acid supplementation for Dermatomyositis and Juvenile Dermatomyositis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Environmental Risk Factors for Myositis in Military Personnel
A completed NIEHS-sponsored clinical study evaluated environmental risk factors for myositis in military personnel, including dermatomyositi…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Adult and Juvenile Myositis
This entry reports that a NIEHS-sponsored clinical trial investigating adult and juvenile myositis is currently recruiting for dermatomyosit…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy [Phase 2, Phase 3]
An open-label Phase 2/3 trial to evaluate the safety and efficacy of CABA-201 in active idiopathic inflammatory myopathy and related juvenil…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] [Phase 3]
Pfizer is conducting a Phase 3 trial of PF-06823859 to study its effects in people with active idiopathic inflammatory myopathies, specifica…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy [Phase 3]
A Phase 3 trial evaluating the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with active idiopathic …
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO [Phase 1]
Phase 1 trial evaluating nivolumab in patients with autoimmune disorders and advanced cancers; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis) [Phase 3]
A Phase 3 trial to evaluate the efficacy and safety of subcutaneous anifrolumab added to standard of care versus placebo with standard of ca…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Environmental Risk Factors for the Anti-synthetase Syndrome
This NIEHS-sponsored clinical trial investigates environmental risk factors for anti-synthetase syndrome, enrolling patients with inflammato…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Construction of a Clinico-Imaging Collaborative Diagnostic Model for Dermatomyositis Combined With Interstitial Lung Disease Based on PET/CT Imaging Features and Clinical Parameters
A clinical trial update on building a clinico-imaging diagnostic model for Dermatomyositis with interstitial lung disease using PET/CT featu…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study [Phase 2]
Phase 2 trial update for emapalumab in rapidly progressive interstitial lung disease associated with dermatomyositis; the study is not yet r…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies [Phase 3]
This is a Phase 3 clinical trial investigating how the study drug Dazukibart works in people with Dermatomyositis and Polymyositis, with rec…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) [Phase 1]
Phase 1b long-term extension trial of RAY121 in multiple immunological diseases is currently enrolling by invitation, expanding early-phase …
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM) [Phase 2, Phase 3]
The sponsor reports an ongoing Phase 2/3 trial assessing the safety and efficacy of ULSC in reducing disease severity and aiding steroid tap…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)
This entry reports a recruiting clinical trial at the University of Pennsylvania evaluating the responsiveness of dermatomyositis using the …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Add-on Intravenous Immunoglobulins in Early Myositis [Phase 2, Phase 3]
A Phase 2/Phase 3 add-on intravenous immunoglobulin study for early inflammatory myopathies (myositis) is active but not currently recruitin…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases
This Clinical Trial Update notes that studies on the natural history and pathogenesis of autoimmune and connective tissue diseases have comp…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Rheumatology Patient Registry and Biorepository
This Clinical Trial Update describes a Yale University-led rheumatology patient registry and biorepository that is currently recruiting to c…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
A long-term follow-up study for participants previously treated with KYV-101; recruitment is ongoing across multiple autoimmune diseases.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: RCT of Tocilizumab for Anti-MDA5+DM [NA]
A randomized controlled trial evaluating tocilizumab for Anti-MDA5-positive dermatomyositis is currently recruiting at Peking Union Medical …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
The MIHRA PRISMS clinical study for myositis is currently recruiting, sponsored by the Myositis International Health & Research Collaborativ…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Panniculitis in Dermatomyositis
A clinical trial investigating panniculitis in dermatomyositis is currently recruiting at University Hospital, Strasbourg, France.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis [Phase 2]
Phase 2 clinical trial of GLPG3667 for dermatomyositis is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES
A clinical trial update on the severity factors of dermatomyositis in the Caribbean population (DM-ANTILLES) currently recruiting.
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis [Phase 2]
A Phase 2 clinical trial evaluating topical ruxolitinib cream for refractory cutaneous dermatomyositis is currently recruiting.